source
- Lilly advances retatrutide toward sleep-apnea marketEli Lilly is moving its triple-agonist drug retatrutide closer to a potential launch for sleep-apnea. The company, which expects to introduce the drug for obesity next year, is now gathering data i…
- GSK gets FDA approval for hepatitis B drug that offers functional cureThe approval of GSK and Ionis’ chronic hepatitis B drug bepirovirsen came early, setting it up to eventually reach blockbuster status. But the FDA gave the drug, now branded Hibsago, aEndpoints · 1h ago↗ source
- Rapport Therapeutics' epilepsy drug RAP-219 meets primary endpoint in bipolar mania Phase II trial